Literature DB >> 2028499

Hypothermia prevents ischemia-induced increases in hippocampal glycine concentrations in rabbits.

A J Baker1, M H Zornow, M R Grafe, M S Scheller, S R Skilling, D H Smullin, A A Larson.   

Abstract

We subjected 10 New Zealand White rabbits to 10 minutes of global cerebral ischemia under either normothermic (37 degrees C) or moderately hypothermic (29 degrees C) conditions. Hippocampal concentrations of glutamate, aspartate, and glycine were monitored using in vivo microdialysis. Outcome was assessed by both neurological and neuropathologic criteria. Hypothermia afforded nearly complete protection from ischemic injury. Ischemia-induced increases in the concentrations of glutamate, aspartate, and glycine in the normothermic group (3, 12, and 3 times baseline) were strikingly attenuated in the hypothermic group. In addition, the prolonged postischemic elevation of glycine levels seen in the normothermic group was absent in the hypothermic group. These results suggest that the neuroprotective properties of hypothermia may reside, in part, in their ability to prevent increases in the extracellular concentrations of amino acids that enhance the activity of the N-methyl-D-aspartate receptor complex.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2028499     DOI: 10.1161/01.str.22.5.666

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  26 in total

1.  Ultrafast and whole-body cooling with total liquid ventilation induces favorable neurological and cardiac outcomes after cardiac arrest in rabbits.

Authors:  M Chenoune; F Lidouren; C Adam; S Pons; L Darbera; P Bruneval; B Ghaleh; R Zini; J-L Dubois-Randé; P Carli; B Vivien; J-D Ricard; A Berdeaux; R Tissier
Journal:  Circulation       Date:  2011-08-01       Impact factor: 29.690

2.  Hypothermic liquid ventilation prevents early hemodynamic dysfunction and cardiovascular mortality after coronary artery occlusion complicated by cardiac arrest in rabbits.

Authors:  Lys Darbera; Mourad Chenoune; Fanny Lidouren; Matthias Kohlhauer; Clovis Adam; Patrick Bruneval; Bijan Ghaleh; Jean-Luc Dubois-Randé; Pierre Carli; Benoit Vivien; Jean-Damien Ricard; Alain Berdeaux; Renaud Tissier
Journal:  Crit Care Med       Date:  2013-12       Impact factor: 7.598

3.  Glycine receptors support excitatory neurotransmitter release in developing mouse visual cortex.

Authors:  Portia A Kunz; Alain C Burette; Richard J Weinberg; Benjamin D Philpot
Journal:  J Physiol       Date:  2012-09-17       Impact factor: 5.182

Review 4.  Hypothermia for acute brain injury--mechanisms and practical aspects.

Authors:  H Alex Choi; Neeraj Badjatia; Stephan A Mayer
Journal:  Nat Rev Neurol       Date:  2012-02-28       Impact factor: 42.937

5.  GFAP-immunoreactivity following hypothermic forebrain ischemia.

Authors:  K Kumar; X Wu; A T Evans
Journal:  Metab Brain Dis       Date:  1997-03       Impact factor: 3.584

Review 6.  Postischemic hypothermia. A critical appraisal with implications for clinical treatment.

Authors:  F Colbourne; G Sutherland; D Corbett
Journal:  Mol Neurobiol       Date:  1997-06       Impact factor: 5.590

Review 7.  Investigational therapies for ischemic stroke: neuroprotection and neurorecovery.

Authors:  Preeti Sahota; Sean I Savitz
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

Review 8.  Hypothermia as a cytoprotective strategy in ischemic tissue injury.

Authors:  Xian N Tang; Midori A Yenari
Journal:  Ageing Res Rev       Date:  2009-10-13       Impact factor: 10.895

9.  Neuronal damage, glial response and cerebral metabolism after hypothermic forebrain ischemia in the rat.

Authors:  H Chen; M Chopp; Q Jiang; J H Garcia
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

10.  Mediation of the neuroprotective action of R-phenylisopropyl-adenosine through a centrally located adenosine A1 receptor.

Authors:  D G MacGregor; W J Miller; T W Stone
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.